APPLE (2020)

The top U.S. infectious disease official said Gilead Sciences Inc's experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early results from a key clinical trial on Wednesday showed it helped patients recover more quickly from the illness...



Comments

No comments yet. Be the first to comment!

Related Chunks

Related chunks with this resource

This Article can be found in 1 chunk
Treating the symptoms - Researching Possible Treatments for COVID19 - Coronavirus

MORE RESOURCES FROM SOURCE

More in FoundryBase from   https://apple.news